![Key regulatory changes that occur with common neuroblastoma therapy – National Cancer Institute](https://oncodaily.com/pub/uploads/2024/06/image-11.png)
Logo of National Cancer Institute from commons.wikimedia.org
Jun 24, 2024, 01:23
Key regulatory changes that occur with common neuroblastoma therapy – National Cancer Institute
National Cancer Institute shared a post on X:
“Investigators at the NCI Center for Cancer Research have mapped key regulatory changes that occur when a common neuroblastoma therapy, retinoic acid, drives tumor cells to develop into neurons, thereby curbing their growth. Learn more.”
Source: National Cancer Institute/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023